<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-12-01" modified="2020-08-12" version="190">
<accession>Q99708</accession>
<accession>A6NKN2</accession>
<accession>A8K8W6</accession>
<accession>E7ETY1</accession>
<accession>O75371</accession>
<accession>Q8NHQ3</accession>
<name>CTIP_HUMAN</name>
<protein>
<recommendedName>
<fullName>DNA endonuclease RBBP8</fullName>
<ecNumber>3.1.-.-</ecNumber>
</recommendedName>
<alternativeName>
<fullName>CtBP-interacting protein</fullName>
<shortName>CtIP</shortName>
</alternativeName>
<alternativeName>
<fullName>Retinoblastoma-binding protein 8</fullName>
<shortName>RBBP-8</shortName>
</alternativeName>
<alternativeName>
<fullName>Retinoblastoma-interacting protein and myosin-like</fullName>
<shortName>RIM</shortName>
</alternativeName>
<alternativeName>
<fullName>Sporulation in the absence of SPO11 protein 2 homolog</fullName>
<shortName>SAE2</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">RBBP8</name>
<name type="synonym">CTIP</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Genomics" volume="51" first="351" last="358">
<title>Molecular cloning and characterization of a novel retinoblastoma-binding protein.</title>
<authorList>
<person name="Fusco C."/>
<person name="Reymond A."/>
<person name="Zervos A.S."/>
</authorList>
<dbReference type="PubMed" id="9721205"/>
<dbReference type="DOI" id="10.1006/geno.1998.5368"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>INTERACTION WITH RB1</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="8549" last="8552">
<title>Interaction between a cellular protein that binds to the C-terminal region of adenovirus E1A (CtBP) and a novel cellular protein is disrupted by E1A through a conserved PLDLS motif.</title>
<authorList>
<person name="Schaeper U."/>
<person name="Subramanian T."/>
<person name="Lim L."/>
<person name="Boyd J.M."/>
<person name="Chinnadurai G."/>
</authorList>
<dbReference type="PubMed" id="9535825"/>
<dbReference type="DOI" id="10.1074/jbc.273.15.8549"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>INTERACTION WITH CTBP1</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
<source>
<tissue>Endometrial cancer</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2005" name="Nature" volume="437" first="551" last="555">
<title>DNA sequence and analysis of human chromosome 18.</title>
<authorList>
<person name="Nusbaum C."/>
<person name="Zody M.C."/>
<person name="Borowsky M.L."/>
<person name="Kamal M."/>
<person name="Kodira C.D."/>
<person name="Taylor T.D."/>
<person name="Whittaker C.A."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Yang X."/>
<person name="Abouelleil A."/>
<person name="Allen N.R."/>
<person name="Anderson S."/>
<person name="Bloom T."/>
<person name="Bugalter B."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="DeCaprio D."/>
<person name="Engels R."/>
<person name="Garber M."/>
<person name="Gnirke A."/>
<person name="Hafez N."/>
<person name="Hall J.L."/>
<person name="Norman C.H."/>
<person name="Itoh T."/>
<person name="Jaffe D.B."/>
<person name="Kuroki Y."/>
<person name="Lehoczky J."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Mauceli E."/>
<person name="Mikkelsen T.S."/>
<person name="Naylor J.W."/>
<person name="Nicol R."/>
<person name="Nguyen C."/>
<person name="Noguchi H."/>
<person name="O'Leary S.B."/>
<person name="Piqani B."/>
<person name="Smith C.L."/>
<person name="Talamas J.A."/>
<person name="Topham K."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Wain H.M."/>
<person name="Young S.K."/>
<person name="Zeng Q."/>
<person name="Zimmer A.R."/>
<person name="Fujiyama A."/>
<person name="Hattori M."/>
<person name="Birren B.W."/>
<person name="Sakaki Y."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="16177791"/>
<dbReference type="DOI" id="10.1038/nature03983"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="18541" last="18549">
<title>Nuclear localization and cell cycle-specific expression of CtIP, a protein that associates with the BRCA1 tumor suppressor.</title>
<authorList>
<person name="Yu X."/>
<person name="Baer R."/>
</authorList>
<dbReference type="PubMed" id="10764811"/>
<dbReference type="DOI" id="10.1074/jbc.m909494199"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH BRCA1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="Nature" volume="406" first="210" last="215">
<title>Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response.</title>
<authorList>
<person name="Li S."/>
<person name="Ting N.S.Y."/>
<person name="Zheng L."/>
<person name="Chen P.-L."/>
<person name="Ziv Y."/>
<person name="Shiloh Y."/>
<person name="Lee E.Y.-H.P."/>
<person name="Lee W.-H."/>
</authorList>
<dbReference type="PubMed" id="10910365"/>
<dbReference type="DOI" id="10.1038/35018134"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-664 AND SER-745</scope>
<scope>MUTAGENESIS OF SER-664 AND SER-745</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="7849" last="7856">
<title>The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity.</title>
<authorList>
<person name="Sum E.Y."/>
<person name="Peng B."/>
<person name="Yu X."/>
<person name="Chen J."/>
<person name="Byrne J."/>
<person name="Lindeman G.J."/>
<person name="Visvader J.E."/>
</authorList>
<dbReference type="PubMed" id="11751867"/>
<dbReference type="DOI" id="10.1074/jbc.m110603200"/>
</citation>
<scope>INTERACTION WITH LMO4</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2003" name="Oncogene" volume="22" first="8845" last="8851">
<title>SIAH-1 interacts with CtIP and promotes its degradation by the proteasome pathway.</title>
<authorList>
<person name="Germani A."/>
<person name="Prabel A."/>
<person name="Mourah S."/>
<person name="Podgorniak M.-P."/>
<person name="Di Carlo A."/>
<person name="Ehrlich R."/>
<person name="Gisselbrecht S."/>
<person name="Varin-Blank N."/>
<person name="Calvo F."/>
<person name="Bruzzoni-Giovanelli H."/>
</authorList>
<dbReference type="PubMed" id="14654780"/>
<dbReference type="DOI" id="10.1038/sj.onc.1206994"/>
</citation>
<scope>INTERACTION WITH SIAH1</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="26932" last="26938">
<title>Dimerization of CtIP, a BRCA1- and CtBP-interacting protein, is mediated by an N-terminal coiled-coil motif.</title>
<authorList>
<person name="Dubin M.J."/>
<person name="Stokes P.H."/>
<person name="Sum E.Y."/>
<person name="Williams R.S."/>
<person name="Valova V.A."/>
<person name="Robinson P.J."/>
<person name="Lindeman G.J."/>
<person name="Glover J.N."/>
<person name="Visvader J.E."/>
<person name="Matthews J.M."/>
</authorList>
<dbReference type="PubMed" id="15084581"/>
<dbReference type="DOI" id="10.1074/jbc.m313974200"/>
</citation>
<scope>SUBUNIT</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="9478" last="9486">
<title>DNA damage-induced cell cycle checkpoint control requires CtIP, a phosphorylation-dependent binding partner of BRCA1 C-terminal domains.</title>
<authorList>
<person name="Yu X."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="15485915"/>
<dbReference type="DOI" id="10.1128/mcb.24.21.9478-9486.2004"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-327</scope>
<scope>INTERACTION WITH BRCA1</scope>
<scope>MUTAGENESIS OF SER-327</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Genes Dev." volume="20" first="1721" last="1726">
<title>BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP.</title>
<authorList>
<person name="Yu X."/>
<person name="Fu S."/>
<person name="Lai M."/>
<person name="Baer R."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="16818604"/>
<dbReference type="DOI" id="10.1101/gad.1431006"/>
</citation>
<scope>INTERACTION WITH BRCA1</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF SER-327</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="3124" last="3134">
<title>CtIP activates its own and cyclin D1 promoters via the E2F/RB pathway during G1/S progression.</title>
<authorList>
<person name="Liu F."/>
<person name="Lee W.H."/>
</authorList>
<dbReference type="PubMed" id="16581787"/>
<dbReference type="DOI" id="10.1128/mcb.26.8.3124-3134.2006"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="Mol. Cancer Res." volume="5" first="1285" last="1295">
<title>CtIP silencing as a novel mechanism of tamoxifen resistance in breast cancer.</title>
<authorList>
<person name="Wu M."/>
<person name="Soler D.R."/>
<person name="Abba M.C."/>
<person name="Nunez M.I."/>
<person name="Baer R."/>
<person name="Hatzis C."/>
<person name="Llombart-Cussac A."/>
<person name="Llombart-Bosch A."/>
<person name="Aldaz C.M."/>
</authorList>
<dbReference type="PubMed" id="18171986"/>
<dbReference type="DOI" id="10.1158/1541-7786.mcr-07-0126"/>
</citation>
<scope>DISEASE</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="Nature" volume="450" first="509" last="514">
<title>Human CtIP promotes DNA end resection.</title>
<authorList>
<person name="Sartori A.A."/>
<person name="Lukas C."/>
<person name="Coates J."/>
<person name="Mistrik M."/>
<person name="Fu S."/>
<person name="Bartek J."/>
<person name="Baer R."/>
<person name="Lukas J."/>
<person name="Jackson S.P."/>
</authorList>
<dbReference type="PubMed" id="17965729"/>
<dbReference type="DOI" id="10.1038/nature06337"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-326; SER-349 AND SER-679</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH BRCA1; MRE11 AND RAD50</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Hum. Mol. Genet." volume="18" first="1869" last="1878">
<title>Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival.</title>
<authorList>
<person name="Quaye L."/>
<person name="Dafou D."/>
<person name="Ramus S.J."/>
<person name="Song H."/>
<person name="Gentry-Maharaj A."/>
<person name="Notaridou M."/>
<person name="Hogdall E."/>
<person name="Kjaer S.K."/>
<person name="Christensen L."/>
<person name="Hogdall C."/>
<person name="Easton D.F."/>
<person name="Jacobs I."/>
<person name="Menon U."/>
<person name="Pharoah P.D."/>
<person name="Gayther S.A."/>
</authorList>
<dbReference type="PubMed" id="19270026"/>
<dbReference type="DOI" id="10.1093/hmg/ddp107"/>
</citation>
<scope>ASSOCIATION WITH OVARIAN CANCER SURVIVAL</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="9558" last="9565">
<title>Human CtIP mediates cell cycle control of DNA end resection and double strand break repair.</title>
<authorList>
<person name="Huertas P."/>
<person name="Jackson S.P."/>
</authorList>
<dbReference type="PubMed" id="19202191"/>
<dbReference type="DOI" id="10.1074/jbc.m808906200"/>
</citation>
<scope>FUNCTION</scope>
<scope>DNA-BINDING</scope>
<scope>PHOSPHORYLATION AT THR-847</scope>
<scope>MUTAGENESIS OF THR-847</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="31746" last="31752">
<title>N terminus of CtIP is critical for homologous recombination-mediated double-strand break repair.</title>
<authorList>
<person name="Yuan J."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="19759395"/>
<dbReference type="DOI" id="10.1074/jbc.m109.023424"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MRE11; RAD50 AND NBN</scope>
<scope>MUTAGENESIS OF HIS-31; VAL-35; LYS-41 AND LEU-45</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Mol. Cell" volume="36" first="954" last="969">
<title>CtIP links DNA double-strand break sensing to resection.</title>
<authorList>
<person name="You Z."/>
<person name="Shi L.Z."/>
<person name="Zhu Q."/>
<person name="Wu P."/>
<person name="Zhang Y.W."/>
<person name="Basilio A."/>
<person name="Tonnu N."/>
<person name="Verma I.M."/>
<person name="Berns M.W."/>
<person name="Hunter T."/>
</authorList>
<dbReference type="PubMed" id="20064462"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.12.002"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-513 AND LYS-515</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-723</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="Science" volume="329" first="1348" last="1353">
<title>Human SIRT6 promotes DNA end resection through CtIP deacetylation.</title>
<authorList>
<person name="Kaidi A."/>
<person name="Weinert B.T."/>
<person name="Choudhary C."/>
<person name="Jackson S.P."/>
</authorList>
<dbReference type="PubMed" id="20829486"/>
<dbReference type="DOI" id="10.1126/science.1192049"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACETYLATION AT LYS-432; LYS-526 AND LYS-604</scope>
<scope>INTERACTION WITH SIRT6</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>MUTAGENESIS OF LYS-432; LYS-526 AND LYS-604</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="Cancer Res." volume="71" first="5792" last="5805">
<title>Modification of BRCA1-associated breast and ovarian cancer risk by BRCA1-interacting genes.</title>
<authorList>
<person name="Rebbeck T.R."/>
<person name="Mitra N."/>
<person name="Domchek S.M."/>
<person name="Wan F."/>
<person name="Friebel T.M."/>
<person name="Tran T.V."/>
<person name="Singer C.F."/>
<person name="Tea M.K."/>
<person name="Blum J.L."/>
<person name="Tung N."/>
<person name="Olopade O.I."/>
<person name="Weitzel J.N."/>
<person name="Lynch H.T."/>
<person name="Snyder C.L."/>
<person name="Garber J.E."/>
<person name="Antoniou A.C."/>
<person name="Peock S."/>
<person name="Evans D.G."/>
<person name="Paterson J."/>
<person name="Kennedy M.J."/>
<person name="Donaldson A."/>
<person name="Dorkins H."/>
<person name="Easton D.F."/>
<person name="Rubinstein W.S."/>
<person name="Daly M.B."/>
<person name="Isaacs C."/>
<person name="Nevanlinna H."/>
<person name="Couch F.J."/>
<person name="Andrulis I.L."/>
<person name="Freidman E."/>
<person name="Laitman Y."/>
<person name="Ganz P.A."/>
<person name="Tomlinson G.E."/>
<person name="Neuhausen S.L."/>
<person name="Narod S.A."/>
<person name="Phelan C.M."/>
<person name="Greenberg R."/>
<person name="Nathanson K.L."/>
</authorList>
<dbReference type="PubMed" id="21799032"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-11-0773"/>
</citation>
<scope>ASSOCIATION WITH BREAST CANCER</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2011" name="PLoS Genet." volume="7" first="E1002310" last="E1002310">
<title>CtIP mutations cause Seckel and Jawad syndromes.</title>
<authorList>
<person name="Jackson S.P."/>
<person name="Borglum A.D."/>
</authorList>
<dbReference type="PubMed" id="21998596"/>
<dbReference type="DOI" id="10.1371/journal.pgen.1002310"/>
</citation>
<scope>INVOLVEMENT IN JWDS</scope>
<scope>INVOLVEMENT IN SCKL2</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-233; THR-315; SER-327; SER-379 AND SER-723</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2013" name="Mol. Cell" volume="50" first="333" last="343">
<title>Prolyl isomerase PIN1 regulates DNA double-strand break repair by counteracting DNA end resection.</title>
<authorList>
<person name="Steger M."/>
<person name="Murina O."/>
<person name="Huehn D."/>
<person name="Ferretti L.P."/>
<person name="Walser R."/>
<person name="Haenggi K."/>
<person name="Lafranchi L."/>
<person name="Neugebauer C."/>
<person name="Paliwal S."/>
<person name="Janscak P."/>
<person name="Gerrits B."/>
<person name="Del Sal G."/>
<person name="Zerbe O."/>
<person name="Sartori A.A."/>
</authorList>
<dbReference type="PubMed" id="23623683"/>
<dbReference type="DOI" id="10.1016/j.molcel.2013.03.023"/>
</citation>
<scope>INTERACTION WITH BRCA1; MRE11 AND PIN1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF SER-276 AND THR-315</scope>
<scope>PHOSPHORYLATION AT SER-276 AND THR-315</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2014" name="EMBO J." volume="33" first="2860" last="2879">
<title>APC/C(Cdh1) controls CtIP stability during the cell cycle and in response to DNA damage.</title>
<authorList>
<person name="Lafranchi L."/>
<person name="de Boer H.R."/>
<person name="de Vries E.G."/>
<person name="Ong S.E."/>
<person name="Sartori A.A."/>
<person name="van Vugt M.A."/>
</authorList>
<dbReference type="PubMed" id="25349192"/>
<dbReference type="DOI" id="10.15252/embj.201489017"/>
</citation>
<scope>INTERACTION WITH FZR1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION DURING THE CELL CYCLE</scope>
<scope>MUTAGENESIS OF LYS-179 AND LYS-467</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-869</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-193; LYS-378; LYS-604; LYS-613 AND LYS-869</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2016" name="Nat. Commun." volume="7" first="12628" last="12628">
<title>Cullin3-KLHL15 ubiquitin ligase mediates CtIP protein turnover to fine-tune DNA-end resection.</title>
<authorList>
<person name="Ferretti L.P."/>
<person name="Himmels S.F."/>
<person name="Trenner A."/>
<person name="Walker C."/>
<person name="von Aesch C."/>
<person name="Eggenschwiler A."/>
<person name="Murina O."/>
<person name="Enchev R.I."/>
<person name="Peter M."/>
<person name="Freire R."/>
<person name="Porro A."/>
<person name="Sartori A.A."/>
</authorList>
<dbReference type="PubMed" id="27561354"/>
<dbReference type="DOI" id="10.1038/ncomms12628"/>
</citation>
<scope>INTERACTION WITH CUL3 AND KLHL15</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF SER-276; THR-315; LYS-467; ARG-839; PHE-840 AND TYR-842</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-62; LYS-115; LYS-193; LYS-360; LYS-378; LYS-396; LYS-404; LYS-410; LYS-438; LYS-449; LYS-526; LYS-530; LYS-572; LYS-578; LYS-604; LYS-613; LYS-638; LYS-640; LYS-676; LYS-719; LYS-782 AND LYS-869</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2014" name="Genome Res." volume="24" first="291" last="299">
<title>Genomic analysis of primordial dwarfism reveals novel disease genes.</title>
<authorList>
<person name="Shaheen R."/>
<person name="Faqeih E."/>
<person name="Ansari S."/>
<person name="Abdel-Salam G."/>
<person name="Al-Hassnan Z.N."/>
<person name="Al-Shidi T."/>
<person name="Alomar R."/>
<person name="Sogaty S."/>
<person name="Alkuraya F.S."/>
</authorList>
<dbReference type="PubMed" id="24389050"/>
<dbReference type="DOI" id="10.1101/gr.160572.113"/>
</citation>
<scope>VARIANT SCKL2 TRP-100</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2015" name="Nat. Cell Biol." volume="17" first="1458" last="1470">
<title>Systematic E2 screening reveals a UBE2D-RNF138-CtIP axis promoting DNA repair.</title>
<authorList>
<person name="Schmidt C.K."/>
<person name="Galanty Y."/>
<person name="Sczaniecka-Clift M."/>
<person name="Coates J."/>
<person name="Jhujh S."/>
<person name="Demir M."/>
<person name="Cornwell M."/>
<person name="Beli P."/>
<person name="Jackson S.P."/>
</authorList>
<dbReference type="PubMed" id="26502057"/>
<dbReference type="DOI" id="10.1038/ncb3260"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>INTERACTION WITH RNF138</scope>
<scope>MUTAGENESIS OF LYS-62; LYS-78; LYS-115; LYS-132; LYS-133; LYS-404; LYS-572; LYS-578; LYS-640; LYS-759; LYS-760 AND LYS-782</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2016" name="Nat. Cell Biol." volume="18" first="271" last="280">
<title>EXD2 promotes homologous recombination by facilitating DNA end resection.</title>
<authorList>
<person name="Broderick R."/>
<person name="Nieminuszczy J."/>
<person name="Baddock H.T."/>
<person name="Deshpande R.A."/>
<person name="Gileadi O."/>
<person name="Paull T.T."/>
<person name="McHugh P.J."/>
<person name="Niedzwiedz W."/>
</authorList>
<dbReference type="PubMed" id="26807646"/>
<dbReference type="DOI" id="10.1038/ncb3303"/>
</citation>
<scope>INTERACTION WITH EXD2</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2017" name="Cell Rep." volume="20" first="1921" last="1935">
<title>SAMHD1 promotes DNA end resection to facilitate DNA repair by homologous recombination.</title>
<authorList>
<person name="Daddacha W."/>
<person name="Koyen A.E."/>
<person name="Bastien A.J."/>
<person name="Head P.E."/>
<person name="Dhere V.R."/>
<person name="Nabeta G.N."/>
<person name="Connolly E.C."/>
<person name="Werner E."/>
<person name="Madden M.Z."/>
<person name="Daly M.B."/>
<person name="Minten E.V."/>
<person name="Whelan D.R."/>
<person name="Schlafstein A.J."/>
<person name="Zhang H."/>
<person name="Anand R."/>
<person name="Doronio C."/>
<person name="Withers A.E."/>
<person name="Shepard C."/>
<person name="Sundaram R.K."/>
<person name="Deng X."/>
<person name="Dynan W.S."/>
<person name="Wang Y."/>
<person name="Bindra R.S."/>
<person name="Cejka P."/>
<person name="Rothenberg E."/>
<person name="Doetsch P.W."/>
<person name="Kim B."/>
<person name="Yu D.S."/>
</authorList>
<dbReference type="PubMed" id="28834754"/>
<dbReference type="DOI" id="10.1016/j.celrep.2017.08.008"/>
</citation>
<scope>INTERACTION WITH SAMHD1</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2017" name="Nat. Commun." volume="8" first="985" last="985">
<title>AUNIP/C1orf135 directs DNA double-strand breaks towards the homologous recombination repair pathway.</title>
<authorList>
<person name="Lou J."/>
<person name="Chen H."/>
<person name="Han J."/>
<person name="He H."/>
<person name="Huen M.S.Y."/>
<person name="Feng X.H."/>
<person name="Liu T."/>
<person name="Huang J."/>
</authorList>
<dbReference type="PubMed" id="29042561"/>
<dbReference type="DOI" id="10.1038/s41467-017-01151-w"/>
</citation>
<scope>INTERACTION WITH AUNIP</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<comment type="function">
<text evidence="8 10 11 15 16 17 18 20 21 22 23">Endonuclease that cooperates with the MRE11-RAD50-NBN (MRN) complex in DNA-end resection, the first step of double-strand break (DSB) repair through the homologous recombination (HR) pathway. HR is restricted to S and G2 phases of the cell cycle and preferentially repairs DSBs resulting from replication fork collapse. Key determinant of DSB repair pathway choice, as it commits cells to HR by preventing classical non-homologous end-joining (NHEJ). Functions downstream of the MRN complex and ATM, promotes ATR activation and its recruitment to DSBs in the S/G2 phase facilitating the generation of ssDNA. Component of the BRCA1-RBBP8 complex that regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage (PubMed:10764811, PubMed:10910365, PubMed:15485915, PubMed:16581787, PubMed:16818604, PubMed:17965729, PubMed:19202191, PubMed:19759395, PubMed:20064462, PubMed:20829486). During immunoglobulin heavy chain class-switch recombination, promotes microhomology-mediated alternative end joining (A-NHEJ) and plays an essential role in chromosomal translocations (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="10 12 13 14 15 17 18 21 23 26 28 29 30 31 32 33 34 35">Homodimer; dimerizes via the coiled coil domain (PubMed:15084581). Interacts (via the PXDLS motif) with CTBP1; the interaction is disrupted via binding of the adenovirus E1A to CTBP1 (PubMed:9535825). Component of the BRCA1-RBBP8 complex. Interacts (the Ser-327 phosphorylated form) with BRCA1 (via the C-terminal BRCA1 domains): the interaction occurs in the G2 phase, ubiquitinates RBBP8 and involves RBBP8 in BRCA1-dependent G2/M checkpoint control on DNA damage (PubMed:10764811, PubMed:15485915, PubMed:16818604, PubMed:17965729, PubMed:23623683). Interacts with RB1 (PubMed:9721205). Interacts with the MRN complex. Interacts directly with MRE11; the interaction is required for efficient homologous recombination (HR) and regulation of the MRN complex (PubMed:19759395, PubMed:23623683). Interacts directly with RAD50 (PubMed:19759395). Interacts directly with NBN (PubMed:19759395). Interacts with SIRT6; the interaction deacetylates RBBP8 upon DNA damage (PubMed:20829486). Interacts with LM04 (via the LIM zinc-binding 1 domain) (PubMed:11751867). Interacts with SIAH1 (PubMed:14654780). Interacts with RNF138 (PubMed:26502057). Interacts with EXD2 (PubMed:26807646). Interacts with CUL3 and KLHL15; this interaction leads to RBBP8 proteasomal degradation (PubMed:27561354). Directly interacts with PIN1; this interaction depends upon RBBP8 phosphorylation, predominantly at Thr-315 (PubMed:23623683). Interacts with FZR1; this interaction leads to APC/C-mediated RBBP8 proteasomal degradation (PubMed:25349192). Interacts with AUNIP; leading to recruit RBBP8 to sites of DNA damage (PubMed:29042561, PubMed:10764811, PubMed:11751867, PubMed:14654780, PubMed:15084581, PubMed:15485915, PubMed:16818604, PubMed:17965729, PubMed:19759395, PubMed:20829486, PubMed:23623683, PubMed:25349192, PubMed:26502057, PubMed:26807646, PubMed:27561354, PubMed:9535825, PubMed:9721205). Interacts with SAMHD1 (PubMed:28834754).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745715">
<id>Q99708</id>
</interactant>
<interactant intactId="EBI-349905">
<id>P38398</id>
<label>BRCA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745715">
<id>Q99708</id>
</interactant>
<interactant intactId="EBI-11324738">
<id>Q9NVH0</id>
<label>EXD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745715">
<id>Q99708</id>
</interactant>
<interactant intactId="EBI-944667">
<id>Q9UQ84</id>
<label>EXO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745715">
<id>Q99708</id>
</interactant>
<interactant intactId="EBI-396513">
<id>P49959</id>
<label>MRE11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745715">
<id>Q99708</id>
</interactant>
<interactant intactId="EBI-494844">
<id>O60934</id>
<label>NBN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745715">
<id>Q99708</id>
</interactant>
<interactant intactId="EBI-1801773">
<id>O75475</id>
<label>PSIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745715">
<id>Q99708</id>
</interactant>
<interactant intactId="EBI-491274">
<id>P06400</id>
<label>RB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-745715">
<id>Q99708</id>
</interactant>
<interactant intactId="EBI-745715">
<id>Q99708</id>
<label>RBBP8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10203615">
<id>Q99708-2</id>
</interactant>
<interactant intactId="EBI-8639312">
<id>P25800</id>
<label>LMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10203615">
<id>Q99708-2</id>
</interactant>
<interactant intactId="EBI-2798728">
<id>P61968</id>
<label>LMO4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10203615">
<id>Q99708-2</id>
</interactant>
<interactant intactId="EBI-714158">
<id>Q13526</id>
<label>PIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10203615">
<id>Q99708-2</id>
</interactant>
<interactant intactId="EBI-971439">
<id>Q08999</id>
<label>RBL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="10 18 26">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="10 17 33">Chromosome</location>
</subcellularLocation>
<text evidence="10 17 28">Associates with sites of DNA damage in S/G2 phase (PubMed:10764811, PubMed:25349192). Ubiquitinated RBBP8 binds to chromatin following DNA damage (PubMed:16818604).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q99708-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q99708-2</id>
<name>2</name>
<sequence type="described" ref="VSP_043220"/>
</isoform>
<isoform>
<id>Q99708-3</id>
<name>3</name>
<sequence type="described" ref="VSP_045247 VSP_045248"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="19">Expressed in ER-positive breast cancer lines, but tends to be down-regulated ER-negative cells (at protein level).</text>
</comment>
<comment type="induction">
<text evidence="19 28">Expression is cell-cycle regulated. Levels increase as dividing cells traverse the G1/S boundary (PubMed:18171986). The protein is degraded by the proteasome pathway during mitotic exit. Also degraded in response to DNA damage in G2 cells; this degradation is mediated by the E3 FZR1/APC/C complex (PubMed:25349192).</text>
</comment>
<comment type="domain">
<text>The PXDLS motif binds to a cleft in CtBP proteins.</text>
</comment>
<comment type="domain">
<text>The damage-recruitment motif is required for DNA binding and translocation to sites of DNA damage.</text>
</comment>
<comment type="PTM">
<text evidence="23">Acetylated. Deacetylation by SIRT6 upon DNA damage promotes DNA end resection.</text>
</comment>
<comment type="PTM">
<text evidence="11 15 18 20 26">Hyperphosphorylation upon ionizing radiation results in dissociation from BRCA1. Phosphorylation at Thr-847 by CDK1 is essential for the recruitment to DNA and the DNA repair function. Phosphorylated on Ser-327 as cells enter G2 phase. This phosphorylation is required for binding BRCA1 and for the G2/M DNA damage transition checkpoint control. Phosphorylation at Thr-315, probably catalyzed by CDK2, is required for PIN1-binding, while phosphorylation at Ser-276 serves as a PIN1 isomerization site. Phosphorylation at Thr-315 is cell-cycle dependent. It steadily increases during S phase, peaks at late S/G2 phase, and drops at G1 (PubMed:23623683).</text>
</comment>
<comment type="PTM">
<text evidence="13 17 28 29 31">Ubiquitinated (PubMed:14654780, PubMed:16818604, PubMed:27561354). Ubiquitination at multiple sites by BRCA1 (via its N-terminal RING domain) does not lead to its proteasomal degradation but instead the ubiquitinated RBBP8 binds to chromatin following DNA damage and may play a role in G2/M checkpoint control (PubMed:16818604). Ubiquitinated by RNF138 at its N-terminus (PubMed:26502057). Ubiquitinated through 'Lys-48' by the E3 CUL3-KLHL15 complex; this modification leads to proteasomal degradation (PubMed:27561354). Ubiquitinated by the E3 FZR1/APC/C complex; this modification leads to proteasomal degradation (PubMed:25349192).</text>
</comment>
<comment type="disease" evidence="25 27">
<disease id="DI-03353">
<name>Seckel syndrome 2</name>
<acronym>SCKL2</acronym>
<description>A rare autosomal recessive disorder characterized by proportionate dwarfism of prenatal onset associated with low birth weight, growth retardation, severe microcephaly with a bird-headed like appearance, and mental retardation.</description>
<dbReference type="MIM" id="606744"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="25">
<disease id="DI-03354">
<name>Jawad syndrome</name>
<acronym>JWDS</acronym>
<description>A syndrome characterized by congenital microcephaly, moderately severe mental retardation, and symmetrical digital anomalies. Digital malformations of variable degree include hallux valgus, syndactyly of toes 4 and 5, short fifth fingers, single flexion crease of fifth fingers, polydactyly and synpolydactyly.</description>
<dbReference type="MIM" id="251255"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text evidence="19 24">Genetic variability in RBBP8 is noted as a factor in BRCA1-associated breast cancer risk (PubMed:21799032). Associated with sensitivity to tamoxifen in certain breast cancer cell lines (PubMed:18171986).</text>
</comment>
<comment type="similarity">
<text evidence="38">Belongs to the COM1/SAE2/CtIP family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/RBBP8ID42066ch18q11.html"/>
</comment>
<dbReference type="EC" id="3.1.-.-"/>
<dbReference type="EMBL" id="AF043431">
<property type="protein sequence ID" value="AAC34368.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U72066">
<property type="protein sequence ID" value="AAC14371.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK292481">
<property type="protein sequence ID" value="BAF85170.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX648221">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC091147">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC106033">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471088">
<property type="protein sequence ID" value="EAX01144.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC030590">
<property type="protein sequence ID" value="AAH30590.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11874.1">
<molecule id="Q99708-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11875.1">
<molecule id="Q99708-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002885.1">
<molecule id="Q99708-1"/>
<property type="nucleotide sequence ID" value="NM_002894.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_976036.1">
<molecule id="Q99708-1"/>
<property type="nucleotide sequence ID" value="NM_203291.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_976037.1">
<molecule id="Q99708-3"/>
<property type="nucleotide sequence ID" value="NM_203292.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006722582.1">
<molecule id="Q99708-1"/>
<property type="nucleotide sequence ID" value="XM_006722519.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006722583.1">
<molecule id="Q99708-1"/>
<property type="nucleotide sequence ID" value="XM_006722520.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006722584.1">
<molecule id="Q99708-1"/>
<property type="nucleotide sequence ID" value="XM_006722521.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011524434.1">
<molecule id="Q99708-1"/>
<property type="nucleotide sequence ID" value="XM_011526132.2"/>
</dbReference>
<dbReference type="PDB" id="2L4Z">
<property type="method" value="NMR"/>
<property type="chains" value="A=641-685"/>
</dbReference>
<dbReference type="PDB" id="4D2H">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B/C/D/E/F/G/H=18-52"/>
</dbReference>
<dbReference type="PDBsum" id="2L4Z"/>
<dbReference type="PDBsum" id="4D2H"/>
<dbReference type="SMR" id="Q99708"/>
<dbReference type="BioGRID" id="111867">
<property type="interactions" value="80"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-4441">
<property type="entry name" value="BRCA1-C complex"/>
</dbReference>
<dbReference type="CORUM" id="Q99708"/>
<dbReference type="DIP" id="DIP-24244N"/>
<dbReference type="ELM" id="Q99708"/>
<dbReference type="IntAct" id="Q99708">
<property type="interactions" value="44"/>
</dbReference>
<dbReference type="MINT" id="Q99708"/>
<dbReference type="STRING" id="9606.ENSP00000382628"/>
<dbReference type="iPTMnet" id="Q99708"/>
<dbReference type="PhosphoSitePlus" id="Q99708"/>
<dbReference type="BioMuta" id="RBBP8"/>
<dbReference type="DMDM" id="116242745"/>
<dbReference type="EPD" id="Q99708"/>
<dbReference type="jPOST" id="Q99708"/>
<dbReference type="MassIVE" id="Q99708"/>
<dbReference type="MaxQB" id="Q99708"/>
<dbReference type="PaxDb" id="Q99708"/>
<dbReference type="PeptideAtlas" id="Q99708"/>
<dbReference type="PRIDE" id="Q99708"/>
<dbReference type="ProteomicsDB" id="1422"/>
<dbReference type="ProteomicsDB" id="78424">
<molecule id="Q99708-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="78425">
<molecule id="Q99708-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="7316">
<property type="antibodies" value="426 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="5932"/>
<dbReference type="Ensembl" id="ENST00000327155">
<molecule id="Q99708-1"/>
<property type="protein sequence ID" value="ENSP00000323050"/>
<property type="gene ID" value="ENSG00000101773"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000399722">
<molecule id="Q99708-1"/>
<property type="protein sequence ID" value="ENSP00000382628"/>
<property type="gene ID" value="ENSG00000101773"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000399725">
<molecule id="Q99708-3"/>
<property type="protein sequence ID" value="ENSP00000382630"/>
<property type="gene ID" value="ENSG00000101773"/>
</dbReference>
<dbReference type="GeneID" id="5932"/>
<dbReference type="KEGG" id="hsa:5932"/>
<dbReference type="UCSC" id="uc002ktw.4">
<molecule id="Q99708-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5932"/>
<dbReference type="DisGeNET" id="5932"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000101773.16"/>
<dbReference type="GeneCards" id="RBBP8"/>
<dbReference type="HGNC" id="HGNC:9891">
<property type="gene designation" value="RBBP8"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000101773">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="RBBP8"/>
<dbReference type="MIM" id="251255">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="604124">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="606744">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q99708"/>
<dbReference type="OpenTargets" id="ENSG00000101773"/>
<dbReference type="Orphanet" id="313795">
<property type="disease" value="Jawad syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="808">
<property type="disease" value="Seckel syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA34255"/>
<dbReference type="eggNOG" id="ENOG502QTV5">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000063835"/>
<dbReference type="HOGENOM" id="CLU_019262_0_0_1"/>
<dbReference type="InParanoid" id="Q99708"/>
<dbReference type="KO" id="K20773"/>
<dbReference type="PhylomeDB" id="Q99708"/>
<dbReference type="TreeFam" id="TF106469"/>
<dbReference type="PathwayCommons" id="Q99708"/>
<dbReference type="Reactome" id="R-HSA-5685938">
<property type="pathway name" value="HDR through Single Strand Annealing (SSA)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5685939">
<property type="pathway name" value="HDR through MMEJ (alt-NHEJ)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5685942">
<property type="pathway name" value="HDR through Homologous Recombination (HRR)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693554">
<property type="pathway name" value="Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693568">
<property type="pathway name" value="Resolution of D-loop Structures through Holliday Junction Intermediates"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693579">
<property type="pathway name" value="Homologous DNA Pairing and Strand Exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693607">
<property type="pathway name" value="Processing of DNA double-strand break ends"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693616">
<property type="pathway name" value="Presynaptic phase of homologous DNA pairing and strand exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804756">
<property type="pathway name" value="Regulation of TP53 Activity through Phosphorylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69473">
<property type="pathway name" value="G2/M DNA damage checkpoint"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8953750">
<property type="pathway name" value="Transcriptional Regulation by E2F6"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912446">
<property type="pathway name" value="Meiotic recombination"/>
</dbReference>
<dbReference type="SIGNOR" id="Q99708"/>
<dbReference type="BioGRID-ORCS" id="5932">
<property type="hits" value="623 hits in 878 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="RBBP8">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q99708"/>
<dbReference type="GeneWiki" id="RBBP8"/>
<dbReference type="GenomeRNAi" id="5932"/>
<dbReference type="Pharos" id="Q99708">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q99708"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 18"/>
</dbReference>
<dbReference type="RNAct" id="Q99708">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000101773">
<property type="expression patterns" value="Expressed in testis and 221 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q99708">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q99708">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0035861">
<property type="term" value="C:site of double-strand break"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0017053">
<property type="term" value="C:transcription repressor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003684">
<property type="term" value="F:damaged DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000406">
<property type="term" value="F:double-strand/single-strand DNA junction binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003690">
<property type="term" value="F:double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070336">
<property type="term" value="F:flap-structured DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0001103">
<property type="term" value="F:RNA polymerase II repressing transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003697">
<property type="term" value="F:single-stranded DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000014">
<property type="term" value="F:single-stranded DNA endodeoxyribonuclease activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003714">
<property type="term" value="F:transcription corepressor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000403">
<property type="term" value="F:Y-form DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001835">
<property type="term" value="P:blastocyst hatching"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051301">
<property type="term" value="P:cell division"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0000729">
<property type="term" value="P:DNA double-strand break processing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010792">
<property type="term" value="P:DNA double-strand break processing involved in repair via single-strand annealing"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006281">
<property type="term" value="P:DNA repair"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006260">
<property type="term" value="P:DNA replication"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000724">
<property type="term" value="P:double-strand break repair via homologous recombination"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000082">
<property type="term" value="P:G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051321">
<property type="term" value="P:meiotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0070317">
<property type="term" value="P:negative regulation of G0 to G1 transition"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0032355">
<property type="term" value="P:response to estradiol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="IDEAL" id="IID00340"/>
<dbReference type="InterPro" id="IPR019518">
<property type="entry name" value="CtIP_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR013882">
<property type="entry name" value="Ctp1_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR033594">
<property type="entry name" value="RBBP8"/>
</dbReference>
<dbReference type="InterPro" id="IPR033316">
<property type="entry name" value="RBBP8-like"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR15107">
<property type="entry name" value="PTHR15107"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR15107:SF4">
<property type="entry name" value="PTHR15107:SF4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF10482">
<property type="entry name" value="CtIP_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08573">
<property type="entry name" value="SAE2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0132">Cell division</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0242">Dwarfism</keyword>
<keyword id="KW-0255">Endonuclease</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0469">Meiosis</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0498">Mitosis</keyword>
<keyword id="KW-0540">Nuclease</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="DNA endonuclease RBBP8" id="PRO_0000097179">
<location>
<begin position="1"/>
<end position="897"/>
</location>
</feature>
<feature type="region of interest" description="Essential for binding to the MRN complex and for RPA focus formation on DNA damage">
<location>
<begin position="22"/>
<end position="45"/>
</location>
</feature>
<feature type="region of interest" description="Damage-recruitment motif">
<location>
<begin position="509"/>
<end position="557"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="9">
<location>
<begin position="28"/>
<end position="157"/>
</location>
</feature>
<feature type="short sequence motif" description="PXDLS motif">
<location>
<begin position="490"/>
<end position="494"/>
</location>
</feature>
<feature type="short sequence motif" description="KLHL15-binding" evidence="31">
<location>
<begin position="840"/>
<end position="842"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="233"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="26">
<location>
<position position="276"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK2" evidence="4 26">
<location>
<position position="315"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="18">
<location>
<position position="326"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 15">
<location>
<position position="327"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="18">
<location>
<position position="349"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="379"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="23">
<location>
<position position="432"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="23">
<location>
<position position="526"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="23">
<location>
<position position="604"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATM" evidence="11">
<location>
<position position="664"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="18">
<location>
<position position="679"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4">
<location>
<position position="723"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATM" evidence="11">
<location>
<position position="745"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK1" evidence="20">
<location>
<position position="847"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7">
<location>
<position position="62"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7">
<location>
<position position="115"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6 7">
<location>
<position position="193"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7">
<location>
<position position="360"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6 7">
<location>
<position position="378"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7">
<location>
<position position="396"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7">
<location>
<position position="404"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7">
<location>
<position position="410"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7">
<location>
<position position="438"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7">
<location>
<position position="449"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="7">
<location>
<position position="526"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7">
<location>
<position position="530"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7">
<location>
<position position="572"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7">
<location>
<position position="578"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="6 7">
<location>
<position position="604"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6 7">
<location>
<position position="613"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7">
<location>
<position position="638"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7">
<location>
<position position="640"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7">
<location>
<position position="676"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7">
<location>
<position position="719"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7">
<location>
<position position="782"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5 6 7">
<location>
<position position="869"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_043220" evidence="36">
<original>S</original>
<variation>SMLFYI</variation>
<location>
<position position="714"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_045247" evidence="37">
<original>RETSLQNFPHIEVVRKKEERRKLLGHTCKECEIYYADMPAEEREKKLASCSRHRFRYIPPNTPENFWEVGFPSTQTCMERGY</original>
<variation>SIMQICQQKKEKRNWLPAQDTDSATFHPTHQRIFGKLVFLPLRLVWKEVILRKILILVLVQKDVSLTTQYFLQKARSRRHRR</variation>
<location>
<begin position="786"/>
<end position="867"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_045248" evidence="37">
<location>
<begin position="868"/>
<end position="897"/>
</location>
</feature>
<feature type="sequence variant" description="In SCKL2; dbSNP:rs373804633." id="VAR_075824" evidence="27">
<original>R</original>
<variation>W</variation>
<location>
<position position="100"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34678569." id="VAR_051308">
<original>K</original>
<variation>N</variation>
<location>
<position position="357"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1804732." id="VAR_028308">
<original>H</original>
<variation>Y</variation>
<location>
<position position="387"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on RPA focus formation on DNA damage." evidence="21">
<original>H</original>
<variation>A</variation>
<location>
<position position="31"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on RPA focus formation on DNA damage." evidence="21">
<original>V</original>
<variation>A</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on RPA focus formation on DNA damage." evidence="21">
<original>K</original>
<variation>A</variation>
<location>
<position position="41"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on RPA focus formation on DNA damage." evidence="21">
<original>L</original>
<variation>A</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="mutagenesis site" description="In K12R; defects in ability to promoting DNA resection and homologous recombination; when associated with R-78; R-115; R-132; R-133; R-404; R-572; R-578; R-640; R-759; R-760 and R-782. In K5R; defects in ability to promoting DNA resection and homologous recombination; when associated with R-78; R-115; R-132 and R-133." evidence="29">
<original>K</original>
<variation>R</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="mutagenesis site" description="In K12R; defects in ability to promoting DNA resection and homologous recombination; when associated with R-62; R-115; R-132; R-133; R-404; R-572; R-578; R-640; R-759; R-760 and R-782. In K5R; defects in ability to promoting DNA resection and homologous recombination; when associated with R-62; R-115; R-132 and R-133." evidence="29">
<original>K</original>
<variation>R</variation>
<location>
<position position="78"/>
</location>
</feature>
<feature type="mutagenesis site" description="In K12R; defects in ability to promoting DNA resection and homologous recombination; when associated with R-62; R-78; R-132; R-133; R-404; R-572; R-578; R-640; R-759; R-760 and R-782. In K5R; defects in ability to promoting DNA resection and homologous recombination; when associated with R-62; R-78; R-132 and R-133." evidence="29">
<original>K</original>
<variation>R</variation>
<location>
<position position="115"/>
</location>
</feature>
<feature type="mutagenesis site" description="In K12R; defects in ability to promoting DNA resection and homologous recombination; when associated with R-62; R-78; R-115; R-133; R-404; R-572; R-578; R-640; R-759; R-760 and R-782. In K5R; defects in ability to promoting DNA resection and homologous recombination; when associated with R-62; R-78; R-115 and R-133." evidence="29">
<original>K</original>
<variation>R</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="mutagenesis site" description="In K12R; defects in ability to promoting DNA resection and homologous recombination; when associated with R-62; R-78; R-115; R-133; R-404; R-572; R-578; R-640; R-759; R-760 and R-782. In K5R; defects in ability to promoting DNA resection and homologous recombination; when associated with R-62; R-78; R-115 and R-132." evidence="29">
<original>K</original>
<variation>R</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on FZR1-binding." evidence="28">
<original>K</original>
<variation>A</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on PIN1-binding. Impaired PIN1-binding, partially decreased CUL3/KLHL15-mediated proteasomal degradation, no effect on BRCA1-, MRE11-, nor on KLHL15-binding; when associated with A-315." evidence="26 31">
<original>S</original>
<variation>A</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased PIN1-binding. Impaired PIN1-binding, partially decreased CUL3/KLHL15-mediated proteasomal degradation, no effect on BRCA1-, MRE11-, nor on KLHL15-binding; when associated with A-276." evidence="26 31">
<original>T</original>
<variation>A</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes BRCA1 interaction and ubiquitination. No activation of CHEK1 after DNA damage." evidence="15 17">
<original>S</original>
<variation>A</variation>
<location>
<position position="327"/>
</location>
</feature>
<feature type="mutagenesis site" description="In K12R; defects in ability to promoting DNA resection and homologous recombination; when associated with R-62; R-78; R-115; R-132; R-133; R-572; R-578; R-640; R-759; R-760 and R-782." evidence="29">
<original>K</original>
<variation>R</variation>
<location>
<position position="404"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced acetylation. Alleviates resection defects caused by depletion of SIRT6; when associated with R-526 and R-604." evidence="23">
<original>K</original>
<variation>R</variation>
<location>
<position position="432"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired FZR1-binding and APC/C-mediated polyubiquitination. Increased stability. No effect on MRE11-binding, nor on CUL3/KLHL15-mediated proteasomal degradation. No effect on DNA-en resection activity." evidence="28 31">
<original>K</original>
<variation>A</variation>
<location>
<position position="467"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes damage recruitment capability." evidence="22">
<original>K</original>
<variation>A</variation>
<location>
<position position="513"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes damage recruitment capability." evidence="22">
<original>K</original>
<variation>A</variation>
<location>
<position position="515"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced acetylation. Alleviates resection defects caused by depletion of SIRT6; when associated with R-432 and R-604." evidence="23">
<original>K</original>
<variation>R</variation>
<location>
<position position="526"/>
</location>
</feature>
<feature type="mutagenesis site" description="In K12R; defects in ability to promoting DNA resection and homologous recombination; when associated with R-62; R-78; R-115; R-132; R-133; R-404; R-578; R-640; R-759; R-760 and R-782." evidence="29">
<original>K</original>
<variation>R</variation>
<location>
<position position="572"/>
</location>
</feature>
<feature type="mutagenesis site" description="In K12R; defects in ability to promoting DNA resection and homologous recombination; when associated with R-62; R-78; R-115; R-132; R-133; R-404; R-572; R-640; R-759; R-760 and R-782." evidence="29">
<original>K</original>
<variation>R</variation>
<location>
<position position="578"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced acetylation. Alleviates resection defects caused by depletion of SIRT6; when associated with R-432 and R-526." evidence="23">
<original>K</original>
<variation>R</variation>
<location>
<position position="604"/>
</location>
</feature>
<feature type="mutagenesis site" description="In K12R; defects in ability to promoting DNA resection and homologous recombination; when associated with R-62; R-78; R-115; R-132; R-133; R-404; R-572; R-578; R-759; R-760 and R-782." evidence="29">
<original>K</original>
<variation>R</variation>
<location>
<position position="640"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates dissociation of BRCA1." evidence="11">
<original>S</original>
<variation>A</variation>
<location>
<position position="664"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates dissociation of BRCA1." evidence="11">
<original>S</original>
<variation>A</variation>
<location>
<position position="745"/>
</location>
</feature>
<feature type="mutagenesis site" description="In K12R; defects in ability to promoting DNA resection and homologous recombination; when associated with R-62; R-78; R-115; R-132; R-133; R-404; R-572; R-578; R-640; R-760 and R-782." evidence="29">
<original>K</original>
<variation>R</variation>
<location>
<position position="759"/>
</location>
</feature>
<feature type="mutagenesis site" description="In K12R; defects in ability to promoting DNA resection and homologous recombination; when associated with R-62; R-78; R-115; R-132; R-133; R-404; R-572; R-578; R-640; R-759 and R-782." evidence="29">
<original>K</original>
<variation>R</variation>
<location>
<position position="760"/>
</location>
</feature>
<feature type="mutagenesis site" description="In K12R; defects in ability to promoting DNA resection and homologous recombination; when associated with R-62; R-78; R-115; R-132; R-133; R-404; R-572; R-578; R-640; R-759 and R-760." evidence="29">
<original>K</original>
<variation>R</variation>
<location>
<position position="782"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on CUL3/KLHL15-mediated proteasomal degradation." evidence="31">
<original>R</original>
<variation>A</variation>
<location>
<position position="839"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased CUL3/KLHL15-mediated proteasomal degradation." evidence="31">
<original>F</original>
<variation>A</variation>
<location>
<position position="840"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased interaction with KLHL15, decreased polyubiquitination and CUL3/KLHL15-mediated proteasomal degradation. No effect on DNA-end resection activity." evidence="31">
<original>Y</original>
<variation>A</variation>
<location>
<position position="842"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on KLHL15-binding, nor on CUL3/KLHL15-mediated proteasomal degradation." evidence="31">
<original>Y</original>
<variation>F</variation>
<location>
<position position="842"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA resection." evidence="20">
<original>T</original>
<variation>A</variation>
<location>
<position position="847"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mimics constitutive phosphorylation." evidence="20">
<original>T</original>
<variation>E</variation>
<location>
<position position="847"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC14371." ref="1" evidence="38">
<original>S</original>
<variation>L</variation>
<location>
<position position="4"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BX648221." ref="4" evidence="38">
<original>H</original>
<variation>Q</variation>
<location>
<position position="74"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAF85170." ref="3" evidence="38">
<original>C</original>
<variation>Y</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAF85170." ref="3" evidence="38">
<original>E</original>
<variation>G</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BX648221." ref="4" evidence="38">
<original>D</original>
<variation>G</variation>
<location>
<position position="341"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BX648221." ref="4" evidence="38">
<original>K</original>
<variation>R</variation>
<location>
<position position="515"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAF85170." ref="3" evidence="38">
<original>L</original>
<variation>P</variation>
<location>
<position position="521"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BX648221." ref="4" evidence="38">
<original>L</original>
<variation>P</variation>
<location>
<position position="642"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="18"/>
<end position="50"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="648"/>
<end position="650"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="651"/>
<end position="653"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="662"/>
<end position="666"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="677"/>
<end position="679"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BX648221." ref="4" evidence="38">
<original>S</original>
<variation>G</variation>
<location sequence="Q99708-3">
<position position="862"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2L4Z"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4D2H"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q80YR6"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255"/>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10764811"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10910365"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11751867"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14654780"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15084581"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15485915"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16581787"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16818604"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17965729"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18171986"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19202191"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19759395"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20064462"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20829486"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21799032"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21998596"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23623683"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24389050"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25349192"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26502057"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26807646"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27561354"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28834754"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29042561"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9535825"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9721205"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000305"/>
<sequence length="897" mass="101942" checksum="E028DE56DE55C0F2" modified="2006-10-17" version="2">MNISGSSCGSPNSADTSSDFKDLWTKLKECHDREVQGLQVKVTKLKQERILDAQRLEEFFTKNQQLREQQKVLHETIKVLEDRLRAGLCDRCAVTEEHMRKKQQEFENIRQQNLKLITELMNERNTLQEENKKLSEQLQQKIENDQQHQAAELECEEDVIPDSPITAFSFSGVNRLRRKENPHVRYIEQTHTKLEHSVCANEMRKVSKSSTHPQHNPNENEILVADTYDQSQSPMAKAHGTSSYTPDKSSFNLATVVAETLGLGVQEESETQGPMSPLGDELYHCLEGNHKKQPFEESTRNTEDSLRFSDSTSKTPPQEELPTRVSSPVFGATSSIKSGLDLNTSLSPSLLQPGKKKHLKTLPFSNTCISRLEKTRSKSEDSALFTHHSLGSEVNKIIIQSSNKQILINKNISESLGEQNRTEYGKDSNTDKHLEPLKSLGGRTSKRKKTEEESEHEVSCPQASFDKENAFPFPMDNQFSMNGDCVMDKPLDLSDRFSAIQRQEKSQGSETSKNKFRQVTLYEALKTIPKGFSSSRKASDGNCTLPKDSPGEPCSQECIILQPLNKCSPDNKPSLQIKEENAVFKIPLRPRESLETENVLDDIKSAGSHEPIKIQTRSDHGGCELASVLQLNPCRTGKIKSLQNNQDVSFENIQWSIDPGADLSQYKMDVTVIDTKDGSQSKLGGETVDMDCTLVSETVLLKMKKQEQKGEKSSNEERKMNDSLEDMFDRTTHEEYESCLADSFSQAADEEEELSTATKKLHTHGDKQDKVKQKAFVEPYFKGDERETSLQNFPHIEVVRKKEERRKLLGHTCKECEIYYADMPAEEREKKLASCSRHRFRYIPPNTPENFWEVGFPSTQTCMERGYIKEDLDPCPRPKRRQPYNAIFSPKGKEQKT</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

